famotidine has been researched along with hydroxychloroquine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berlin, JA; Fortin, SP; Ryan, P; Shoaibi, A; Weinstein, R | 1 |
| Baik, SH; Baye, F; Fung, KW; Huser, V; McDonald, CJ; Zheng, Z | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for famotidine and hydroxychloroquine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 other study(ies) available for famotidine and hydroxychloroquine
| Article | Year |
|---|---|
Comparative Effectiveness of Famotidine in Hospitalized COVID-19 Patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cohort Studies; COVID-19; COVID-19 Drug Treatment; Famotidine; Female; Hospitalization; Humans; Hydroxychloroquine; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Young Adult | 2021 |
Effect of common maintenance drugs on the risk and severity of COVID-19 in elderly patients.
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; COVID-19 Drug Treatment; Factor Xa Inhibitors; Famotidine; Humans; Hydroxychloroquine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Medicare; Retrospective Studies; United States; Warfarin | 2022 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |